UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA

International journal of hematology, 2021-12, Vol.114 (6), p.725-734

2021

Volltextzugriff (PDF)

Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation

Pediatric blood & cancer, 2015-09, Vol.62 (9), p.1597-1600

2015

Volltextzugriff (PDF)

Thrombopoietin receptor agonist switch in children with persistent and chronic severe immune thrombocytopenia: A retrospective analysis in a large tertiary center

Pediatric blood & cancer, 2019-06, Vol.66 (6), p.e27704-n/a

2019

Volltextzugriff (PDF)

The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01

Haematologica (Roma), 2014-09, Vol.99 (9), p.1472

2014

Volltextzugriff (PDF)

Alemtuzumab induction in pediatric kidney transplantation

Pediatric transplantation, 2013-03, Vol.17 (2), p.168-178

2013

Volltextzugriff (PDF)

Eight‐year follow‐up in pediatric living donor kidney recipients receiving alemtuzumab induction

Pediatric transplantation, 2017-08, Vol.21 (5), p.n/a

2017

Volltextzugriff (PDF)

Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study

Journal of pediatric hematology/oncology, 2014-07, Vol.36 (5), p.395-401

2014

Volltextzugriff (PDF)

Efficacy and safety of ruxolitinib in ineffective erythropoiesis suppression as a pretransplantation treatment for pediatric patients with beta‐thalassemia major

Pediatric blood & cancer, 2021-11, Vol.68 (11), p.e29338-n/a

2021

Volltextzugriff (PDF)

Quantification of NG2‐positivity for the precise prediction of KMT2A gene rearrangements in childhood acute leukemia

Genes chromosomes & cancer, 2021-02, Vol.60 (2), p.88-99

2021

Volltextzugriff (PDF)

Blinatumomab following haematopoietic stem cell transplantation – a novel approach for the treatment of acute lymphoblastic leukaemia in infants

British journal of haematology, 2021-07, Vol.194 (1), p.174-178

2021

Volltextzugriff (PDF)

Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott–Aldrich syndrome

British journal of haematology, 2021-01, Vol.192 (2), p.366-374

2021

Volltextzugriff (PDF)

Chimerism evaluation in measurable residual disease‐suspected cells isolated by flow cell sorting as a reliable tool for measurable residual disease verification in acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Cytometry. Part B, Clinical cytometry, 2021-09, Vol.100 (5), p.568-573

2021

Volltextzugriff (PDF)

Control of graft‐versus‐host disease with rabbit anti‐thymocyte globulin, rituximab, and bortezomib in TCRαβ/CD19‐depleted graft transplantation for leukemia in children: a single‐center retrospective analysis of two GVHD‐prophylaxis regimens

Pediatric transplantation, 2020-02, Vol.24 (1), p.e13594-n/a

2020

Volltextzugriff (PDF)

Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second Russian‐Belorussian multicentre study B‐NHL‐2010M

British journal of haematology, 2019-08, Vol.186 (3), p.477-483

2019

Volltextzugriff (PDF)

Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials

Pediatric blood & cancer, 2020-11, Vol.67 (11), p.e28630-n/a

2020

Volltextzugriff (PDF)

Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia

Leukemia research, 2021-01, Vol.100, p.106491-106491, Article 106491

2021

Volltextzugriff (PDF)

657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls

American journal of medical genetics, 2003-07, Vol.120A (2), p.174-179

2003

Volltextzugriff (PDF)

FLAER‐negative CD15+ neutrophils can be used for the simplified screening of suspected PNH cases

International journal of laboratory hematology, 2020-10, Vol.42 (5), p.589-593

2020

Volltextzugriff (PDF)

A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age

The Pediatric infectious disease journal, 2019-03, Vol.38 (3), p.275

2019

Volltextzugriff (PDF)

Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria

Blood advances, 2024-06, Vol.8 (11), p.2813-2824

2024

Volltextzugriff (PDF)

Bone Marrow Transplantation for Fanconi Anemia Using Fludarabine-Based Conditioning

Biology of blood and marrow transplantation, 2011-09, Vol.17 (9), p.1282-1288

2011

Volltextzugriff (PDF)

NPM1, FLT3, and c-KIT mutations in pediatric acute myeloid leukemia in Russian population

Journal of pediatric hematology/oncology, 2013-04, Vol.35 (3), p.e100-e108

2013

Volltextzugriff (PDF)

Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients

Nature communications, 2021-12, Vol.12 (1), p.7200-7200, Article 7200

2021

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

ThemaChild, Preschool

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA

Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation

Thrombopoietin receptor agonist switch in children with persistent and chronic severe immune thrombocytopenia: A retrospective analysis in a large tertiary center

The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01

Alemtuzumab induction in pediatric kidney transplantation

Eight‐year follow‐up in pediatric living donor kidney recipients receiving alemtuzumab induction

Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study

Efficacy and safety of ruxolitinib in ineffective erythropoiesis suppression as a pretransplantation treatment for pediatric patients with beta‐thalassemia major

Quantification of NG2‐positivity for the precise prediction of KMT2A gene rearrangements in childhood acute leukemia

Blinatumomab following haematopoietic stem cell transplantation – a novel approach for the treatment of acute lymphoblastic leukaemia in infants

Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott–Aldrich syndrome

Chimerism evaluation in measurable residual disease‐suspected cells isolated by flow cell sorting as a reliable tool for measurable residual disease verification in acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Control of graft‐versus‐host disease with rabbit anti‐thymocyte globulin, rituximab, and bortezomib in TCRαβ/CD19‐depleted graft transplantation for leukemia in children: a single‐center retrospective analysis of two GVHD‐prophylaxis regimens

Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second Russian‐Belorussian multicentre study B‐NHL‐2010M

Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials

Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia

657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls

FLAER‐negative CD15+ neutrophils can be used for the simplified screening of suspected PNH cases

A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age

Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria

Bone Marrow Transplantation for Fanconi Anemia Using Fludarabine-Based Conditioning

NPM1, FLT3, and c-KIT mutations in pediatric acute myeloid leukemia in Russian population

Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients

Aktive Filter

Suchergebnisse filtern